$GALT News Article - Galectin Therapeutics Reports
Post# of 61
(Total Views: 109)
Posted On: 04/09/2024 8:30:47 AM
$GALT News Article - Galectin Therapeutics Reports the Positive Outcome of the Fifth Data and Safety Monitoring Board Meeting for NAVIGATE Phase 2b/3 Study of Belapectin in Patients with Cirrhotic Portal Hypertension Caused by Metabolic Dysfunction-Associated SteatoHepatitis https://marketwirenews.com/news-releases/gale...73648.html
(0)
(0)Galectin Therapeutics Inc (GALT) Stock Research Links
My Twitter: WhyteStocks
Scroll down for more posts ▼